Payer economics are tightening. Medical costs continue to rise faster than premiums, policy uncertainty persists, and growth and profitability are becoming more uneven across Medicare Advantage, Medicaid, commercial, and employer-sponsored insurance products.
Payers must be able to adapt under pressure to keep pace. As payers evaluate key strategic options to meet today’s market realities, they are rationalizing portfolios, fine-tuning products, and reorganizing for profitable growth.
At the same time, scale is concentrating rapidly. Major national payers are projected to cover more than half of Americans over the next decade. Yet today’s payer M&A activity is not just about scale. The volume and nature of transactions reflect a market actively reshaping itself from within. Payers can no longer wait for peak disruption to react; they must respond proactively to tomorrow’s challenges.
A structured, disciplined shift in strategy
Health plan partnerships and M&A activity increasingly reflect a strategic response to mounting market pressures. Payers are becoming more deliberate about where and how they compete—exiting non-core markets and products, concentrating resources in priority geographies, strengthening targeted product lines, and pursuing transactions that enhance scale, capabilities, and long-term competitive positioning.
Membership scale remains a critical threshold for sustainability, particularly as organizations absorb rising utilization, margin compression, and increasingly complex risk-adjustment dynamics. But scale is only a piece of a more complex puzzle.
Payers managing membership across multiple products and technological investments are finding that competitive advantage comes from orchestrating products, member strategy, data, and risk across the healthcare ecosystem.
Independence, while still strategically appealing, is becoming operationally fragile. The level of investment required to diversify products, optimize risk adjustment, expand member reach, strengthen data infrastructure, and compete across multiple product lines and geographies is significant. As a result, many payers are evaluating strategic alternatives and exploring a spectrum of partnership models—from looser affiliations and minority investments to joint ventures and fully integrated platforms—to accelerate access to scale, diversification, and operational resilience. Payer decisions to partner are becoming structural expressions of a broader strategy to strengthen positioning, stabilize economics, expand market access, and remain competitive in an ever more concentrated landscape.
Partnerships serve as proactive tools for portfolio rationalization, member diversification, product expansion, and long-term stabilization.
Partnership
Strategic approach
Braven Health New Jersey
Payer-provider partnership as a long-term operating model for scaling Medicare Advantage products through aligned governance, care coordination, and value-based care capabilities
Kaiser Permanente Nevada
Cross-market geographic expansion through a payer-provider joint venture, integrating health plan and care delivery capabilities to scale value-based care
Humana’s CenterWell Senior Primary Care/The Villages Health
Acquisition of community-based primary care assets to strengthen integrated care delivery and value-based management of Medicare Advantage populations
Priority Health/Wisconsin’s Health Cooperative of Eau Claire
New market entry through a creative governance structure that preserved relevance and geographic strength for a small health plan in a highly competitive market
Sanford Health Plan/Security Health Plan
Health plan integration through a shared management structure designed to enhance scale, operational alignment, and regional competitiveness
HealthSpring
Focused portfolio repositioning through targeted acquisitions and divestitures to sharpen focus on core Medicare capabilities and expand market presence
HCSC/The Cigna Group’s Evernorth Health Services
Service-based partnership providing pharmacy benefit services and other solutions for Medicare insurance products
Responding to an environment that is more uneven, constrained, and difficult to navigate alone is driving disciplined investment decisions in partnerships, acquisitions, mergers, and integrations. Large national players possess broader diversification strategies across pharmacy, services, data, and adjacent businesses, giving them significantly more strategic flexibility. Regional, local, and/or provider-sponsored plans, by contrast, have significantly more opportunity to think creatively about partnerships, member strategy, geographic reach, and product alignment to remain competitive.
Five emerging trends in payer M&A
Scale still matters—but scale alone is no longer sufficient.
Partnerships are proactive rather than reactive.
Portfolio rationalization is reshaping where and how organizations compete.
Regional plans face growing pressure to find creative pathways to relevance and sustainability.
The organizations best positioned for the future are not the biggest—but are the most disciplined in their strategic approach.
Orchestrating the best possible outcomes
The future of payer M&A is less about ownership in the traditional sense and more about shared infrastructure, shared economics, shared reach, and shared approaches to managing risk. Whether through joint ventures, minority investments, strategic affiliations, or more integrated models, health plans are increasingly joining together rather than attempting to operate independently.
What appears to be a wave of M&A is, more fundamentally, a system reorganizing itself around a new reality: no single organization can build every product, manage every risk pool, or compete across every market alone.
The future will belong to payers that can orchestrate effectively across partnerships, products, populations, and platforms.
Key considerations for leaders
For executive and board consideration:
Evaluate strategic pathways, including independence, partnership, affiliation, or acquisition
Assess strengths and gaps across products, member diversification, scale, and market positioning
Identify partners that align across strategy, governance, economics, and long-term objectives
Execute transactions and integrations with rigor and discipline
Authors
Kristofer Blohm
Managing Director, Practice Co-Leader, Mergers & Acquisitions
Kris Blohm is a Managing Director and Co-Leader in Kaufman Hall’s Mergers & Acquisitions practice with more than 20 years of healthcare financial and strategic advisory experience. He counsels executives and boards nationwide on a broad range of transactions, including mergers, acquisitions, partnerships, divestitures, joint ventures, strategic investments, as well as other partnership and affiliation structures. Prior to Kaufman Hall,...
James Tompkins is a Senior Vice President in Kaufman Hall’s Mergers & Acquisitions practice. His focus areas include the evaluation, structuring, negotiation and execution of partnership and other transaction opportunities. Mr. Tompkins has more than 17 years of experience in the healthcare industry and with a broad range of structures, including various collaboration, affiliation and partnership models, buy- and sell-side...
